UMR 1173 INSERM/Versailles Saint-Quentin-en-Yvelines University, Montigny le Bretonneux, France.
Rheumatology Division Ambroise Paré Hospital (AP-HP), Boulogne-Billancourt, France.
Front Immunol. 2018 Dec 18;9:2933. doi: 10.3389/fimmu.2018.02933. eCollection 2018.
Spondyloarthritis (SpA) is a chronic inflammatory disorder with high heritability but with complex genetics. It encompasses several entities that share common clinical features. Most of the genetic studies in SpA have been restricted to ankylosing spondylitis (AS), the prototypical form of SpA. However, there is growing evidence of shared genetic background between all the SpA subtypes and also with some other immune-mediated diseases. The most important part of SpA heritability comes from the HLA-B27 allele in the major histocompatibility complex (MHC) that explains around 25% of the attributable heredity. Several other loci outside of the MHC have been shown to be involved in the disease. However, all these non-MHC loci explain only a small additional fraction of disease predisposition. Thus, a substantial fraction of SpA genetic basis remains poorly understood. Gene expression profiling is a complementary approach to elucidate the underlying mechanisms and pathways that drive the disease. Several expression profiling studies have been undertaken in SpA. However, results have been quite disappointing with little overlap between the studies largely due to the small sample sizes, resulting in limited power to discover small effects. In this review, we summarize current knowledge on genetic findings concerning SpA and we describe strategic approaches for identification of additional variants, with a focus on rare variants in familial forms. We also provide an overview of gene expression studies in SpA and discuss the possibilities offered by high-throughput RNA sequencing technologies, in particular in sorted cells. Finally, issues in establishing molecular mechanisms underlying genetic association hits and potential translational applications will be addressed.
脊柱关节炎(SpA)是一种具有高度遗传性但遗传机制复杂的慢性炎症性疾病。它包含了一些具有共同临床特征的实体。大多数 SpA 的遗传研究都局限于强直性脊柱炎(AS),这是 SpA 的典型形式。然而,越来越多的证据表明所有 SpA 亚型之间以及与一些其他免疫介导的疾病之间存在共同的遗传背景。SpA 遗传的最重要部分来自主要组织相容性复合体(MHC)中的 HLA-B27 等位基因,它解释了约 25%的可归因遗传。已经证明 MHC 以外的几个其他位点也与疾病有关。然而,所有这些非 MHC 位点仅能解释疾病易感性的一小部分额外因素。因此,SpA 遗传基础的很大一部分仍然难以理解。基因表达谱分析是阐明驱动疾病的潜在机制和途径的一种补充方法。已经在 SpA 中进行了几项表达谱研究。然而,由于样本量小,研究结果令人相当失望,研究之间几乎没有重叠,导致发现小效应的能力有限。在这篇综述中,我们总结了有关 SpA 的遗传发现的现有知识,并描述了鉴定其他变体的策略方法,重点是家族形式中的罕见变体。我们还概述了 SpA 的基因表达研究,并讨论了高通量 RNA 测序技术提供的可能性,特别是在分选细胞中。最后,将解决遗传关联命中的分子机制建立问题以及潜在的转化应用。